Candela Medical, which makes energy-based medical devices for aesthetic procedures, postponed its IPO on Thursday. Backed by Apax Partners, Candela had filed to raise $250 million by offering 14.7 million shares at a price range of $16 to $18.
The Marlborough, MA-based company was founded in 2010 and booked $390 million in sales for the 12 months ended June 30, 2021. It had planned to list on the Nasdaq under the symbol CDLA. BofA Securities, Goldman Sachs, Barclays, Baird, Canaccord Genuity, and Stifel were set to be the joint bookrunners on the deal.
